Physician profile
Jonathan D Griffin
NPI 1780204693
$2,847.05
in general payments reported to CMS, 2019-2025
11 companies · $364 in 2025
The $364 reported for 2025 was more than what 87% of Dentist providers received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $19.54 · 2021: $646 · 2022: $902 · 2023: $845 · 2024: $70.72 · 2025: $364.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $940 · Education: $340.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $939.90 |
| Education | $339.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $1,076.60 | 2021-2024 | Trumatch, Matrixorthognathic, Matrixwave |
| Medical Device Business Services, INC. | $683.51 | 2021-2023 | |
| Axogen | $557.92 | 2021-2025 | Avance Nerve Graft |
| Stryker Corporation | $261.95 | 2021-2025 | Patient-Fitted Tmj Reconstructive Prosthesis System |
| Zimmer Biomet Holdings, INC. | $81.54 | 2021-2025 | Traumaone |
| Zimvie INC. | $46.22 | 2023-2024 | |
| Sanara Medtech INC. | $43.55 | 2021 | |
| Checkpoint Surgical, INC | $40.21 | 2022-2025 | Checkpoint Stimulators |
| Kerecis Limited | $19.97 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Medtronic USA, INC. | $19.54 | 2020 | |
| Straumann USA LLC | $16.04 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Griffin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.